NOTV (Inotiv, Inc. Common Stock) Stock Analysis - News
Inotiv, Inc. Common Stock (NOTV) is a publicly traded Healthcare sector company. As of May 21, 2026, NOTV trades at $0.27 with a market cap of $9.04M and a P/E ratio of -0.11. NOTV moved +6.09% today. Year to date, NOTV is -52.86%; over the trailing twelve months it is -87.60%. Its 52-week range spans $0.22 to $6.48. Rallies surfaces NOTV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in NOTV news today?
Inotiv Q1 revenue edges up 0.8% as DSA sales jump 12%: Inotiv Q1 revenue rose 0.8% to $120.9M with DSA sales up 12% to $48.0M while RMS revenue fell 5.4% to $72.9M. Operating loss widened 5.3% to $16.3M and net loss increased to $28.4M as cash reserves dropped to $12.7M.
Taylor Beth A. sold 2.89K (~$845.895) on Feb 17, 2026.
Sagartz John E sold 2.12K (~$616.205) on Feb 17, 2026.
Leasure Robert Jr. sold 16.81K (~$4.96K) on Feb 17, 2026.
NOTV Analyst Consensus
NOTV analyst coverage data. Average price target: $0.00.
Common questions about NOTV
What changed in NOTV news today?
Inotiv Q1 revenue edges up 0.8% as DSA sales jump 12%: Inotiv Q1 revenue rose 0.8% to $120.9M with DSA sales up 12% to $48.0M while RMS revenue fell 5.4% to $72.9M. Operating loss widened 5.3% to $16.3M and net loss increased to $28.4M as cash reserves dropped to $12.7M.
Does Rallies summarize NOTV news?
Yes. Rallies summarizes NOTV news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is NOTV research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NOTV. It does not provide personalized investment advice.
